Mediphar Labs. has launched NAUSETRON®oral solution in January 2019 in the Lebanese market.

 

Nausetron®is indicated for the treatment of chemotherapy induced nausea and vomiting (CINV). It is also highly effective for vomiting due to GASTROENTERITIS, where studies have shown that it reduces vomiting and facilitates oral rehydration. 

We are proud to be the first to introduce oral ondansetron in the form of solution for children, providing patients with effective and more convenient treatment options. Nausetron is also available in tablet form.

Nausetron®is available in the below dosage

  • Ondansetron 4 mg/ 5mL, bottle of 100 mL
  • Ondansetron 8mg, pack of 10 tablets
Back to All News
We care about your questions and concerns. Please call the consumer healthcare service:
+961 4 540056 or by email: chs@medipharlabs.com